David Stark serves as Executive at Stem Cell Therapy International, Inc., where they oversee executive responsibilities. Since joining the company, David Stark has executed 3 insider transactions totaling $963, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 27, 2009 involved receiving (via award) 1,000,000 shares valued at $60.0K.
David Stark currently holds 1,263,942 shares of Stem Cell Therapy International, Inc. (SCII), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David Stark has been a net buyer of SCII stock. They have purchased $963 and sold $0 worth of shares.
David Stark's most recent insider trade was on Jul 27, 2009, when they sold 1,000,000 shares at $0.06 per share.
Get notified when new Form 4 filings are submitted
| $0.06 |
| Discretionary |
| Dec 11, 2008 | SCII | $875 | Purchase | 12,500 | $0.07 | Discretionary |